Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Low to moderate doses of vasopressin have been used in the treatment of cathecholamine‐dependent vasodilatory shock in sepsis or after cardiac surgery. We evaluated the effects of vasopressin on jejunal mucosal perfusion, gastric‐arterial p CO 2 gradient and the global splanchnic oxygen demand/supply relationship in patients with vasodilatory shock after cardiac surgery. Methods: Eight mechanically ventilated patients, dependent on norepinephrine to maintain mean arterial pressure (MAP) ≥60 mmHg because of septic/post‐cardiotomy vasodilatory shock and multiple organ failure after cardiac surgery, were included. Vasopressin was sequentially infused at 1.2, 2.4 and 4.8 U/h for 30‐min periods. Norepinephrine was simultaneously decreased to maintain MAP at 75 mmHg. At each infusion rate of vasopressin, data on systemic hemodynamics, jejunal mucosal perfusion, jejunal mucosal hematocrit and red blood cell velocity (laser Doppler flowmetry) as well as gastric‐arterial p CO 2 gradient (gastric tonometry) and splanchnic oxygen and lactate extraction (hepatic vein catheter) were obtained. Results: The cardiac index, stroke volume index and systemic oxygen delivery decreased and systemic vascular resistance and systemic oxygen extraction increased significantly, while the heart rate or global oxygen consumption did not change with increasing vasopressin dose. Jejunal mucosal perfusion decreased and the arterial‐gastric‐mucosal p CO 2 gradient increased, while splanchnic oxygen or lactate extraction or mixed venous–hepatic venous oxygen saturation gradient were not affected by increasing infusion rates of vasopressin. Conclusions: Infusion of low to moderate doses of vasopressin in patients with norepinephrine‐dependent vasodilatory shock after cardiac surgery induces an intestinal and gastric mucosal vasoconstriction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548 · cited 1×
“lactic acidosis.(1,2) Norepinephrine is the recommended agent and is commonly used for treatment of hypotension in volume-resuscitated hyperdynamic septic shock,(3) and is also used to correct hypotension in the vasodilatory shock syndrome after cardiac surgery with a cardiopulmonary bypass.”
BackgroundVasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990
Physiology of Vasopressin Relevant to Management of Septic Shock
Holmes, C. L., Patel, B. M., Russell, J. A., & Walley, K. R. (2001) · Chest · doi:10.1378/chest.120.3.989 · Cited by 620 · cited 1×
“Previous studies have shown that the cardiac index decreases due to a decrease in the heart rate, while the stroke volume is maintained when norepinephrine is substituted by vasopressin in vasodilatory shock.(5,14,30) The divergent effects of vasopressin on left ventricular performance in those studies and in the pres…”
Background
Cited by
Mancl, E. E., & Muzevich, K. M. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112470460 · Cited by 155
ter Steege, R. W. F., & Kolkman, J. J. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04980.x · Cited by 145
When can we start early enteral nutrition safely in patients with shock on vasopressors?
Wang, L., Zhong, X., Yang, H., Yang, J., Zhang, Y., Zou, X., Wang, L., Zhang, Z., Jin, X., Kang, Y., et al. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.03.007 · Cited by 19
Seilitz, J., Grafver, I., Kiszakiewicz, L., Oikonomakis, I., Jansson, K., Axelsson, B., & Nilsson, K. F. (2021) · Shock · doi:10.1097/shk.0000000000001726 · Cited by 10
“gery when MAP was kept at 75 mm Hg (42).”
Background
Metadata
- Authors
- NYGREN, A., THORÉN, A., & RICKSTEN, S. ‐.
- Venue
- Acta Anaesthesiologica Scandinavica
- Publisher
- Wiley
- Published
- 2009-04-14
- Volume
- 53
- Issue
- 5
- Pages
- 581-588
- ISSN
- 0001-5172 (ISSN-L)
- 1399-6576
- OpenAlex
- W2007932182
- Cited by
- 65
- References
- 3
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock. https://app.cochat.ai/papers/10.1111/j.1399-6576.2008.01900.x
- The paper
- NYGREN, A., THORÉN, A., & RICKSTEN, S. ‐. (2009). Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/j.1399-6576.2008.01900.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.